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Myogenic Differentiation of Adipose-Derived Stem Cells for Tissue
Engineering
India Pursell1, Heather Vogel1, Haley Barnett 1, 2, Mary Caldorera-Moore3, and Jamie Newman1
¹School of Biological Sciences, Louisiana Tech University
²Graduate Program in Molecular Sciences & Nanotechnology, Louisiana Tech University
3
Department of Biomedical Engineering, Louisiana Tech University
Volumetric muscle loss (VML) is characterized by muscle injury where the tissue is not able to
regenerate naturally. This can occur from combat injuries, traumatic injuries such as car wrecks,
surgical procedures such as tumor removal, or abnormal muscle conditions such as muscular
dystrophies. There are currently no treatment options for de novo muscle regeneration or
function for patients suffering from VML. Multipotent stem cells, such as human adipose stem
cells (hASCs), offer the most promise in cell-based regenerative therapies due to their selfrenewing capabilities, their ability to differentiate into cells found in mesoderm tissues and the
ease with which they can be harvested from patients. hASCs have the potential to differentiate
towards a myogenic linage, however, there is currently no differentiation media that can yield
more than 15% myogenic success. Here we focus on optimizing a myogenic differentiation
media recipes for hASCs. Initially, two myogenic medias were investigated for their
differentiation potential at 2, 4, and 6 weeks of hASC culture. Reverse transcription polymerase
chain reaction (RTPCR) was utilized to determine if common myogenic markers, desmin, myf5,
myf6, myogenin, mhc, and myod were expressed in hASCs after exposure to these medias.
Immunofluorescence using the antimyosin antibody was also used to qualitatively evaluate
differentiation. From these assays we identified a media recipe that reproducibly induces
myogenic differentiation and we are currently testing different culture environments to continue
working towards the creation of functional muscle tissue for clinical applications
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